3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
96
Rectal Neoplasms
42
Colonic Neoplasms
38
Stomach Neoplasms
31
Pancreatic Neoplasms
31
Neoplasm Metastasis
24
Precursor Cell Lymphoblastic Leukemia-Lymphoma
23
Neoplasms
21
Esophageal Neoplasms
19
Burkitt Lymphoma
15
Adenocarcinoma Of Esophagus
14
Lymphoma
13
Leukemia
8
Adenocarcinoma
6
Parkinson Disease 4, Autosomal Dominant Lewy Body
5
Osteosarcoma
5
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
4
Lymphoma, Non-Hodgkin
4
Lymphoma, Mantle-Cell
4
Leukemia, Biphenotypic, Acute
4
Gastrointestinal Neoplasms
4
Gallbladder Neoplasms
4
Carcinoma, Hepatocellular
4
Liver Neoplasms
3
Intestinal Neoplasms
3
Esophageal Squamous Cell Carcinoma
3
Cholangiocarcinoma
3
Carcinoma, Non-Small-Cell Lung
3
Bile Duct Neoplasms
3
Somatostatinoma
2
Interventions
Nivolumab
4
pertuzumab
2
pembrolizumab
2
durvalumab
2
Paclitaxel
2
Docetaxel
2
Capecitabine
2
ulocuplumab
1
tremelimumab
1
tazarotene
1
talazoparib
1
romiplostim
1
pexidartinib
1
pamiparib
1
onartuzumab
1
magrolimab
1
entrectinib
1
cobimetinib
1
atezolizumab
1
Sunitinib
1
Rifampin
1
Ramucirumab
1
Radiosurgery
1
N-benzhydryl-5-(2-(methylamino)propanamido)-3-(3-methylbutanoyl)-6-oxodecahydropyrrolo(1,2-a)(1,5)diazocine-8-carboxamide
1
Midazolam
1
MK-4166
1
LY3022855
1
LY2510924
1
LY-2157299
1
Itraconazole
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Solid Tumor
×
Leucovorin
×
Clear all
No trials found.